The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share. The biotechnology company posted ...
News
- Cara: Q3 Earnings Snapshot - Laredo Morning Times
- Why Blade Therapeutics ditched an IPO for a blank-check merger - San Francisco Business Times
Aiming at a deadly lung-scarring disease that has stopped other drug developers, a Peninsula biotech company plans to raise $254.3 million through ...
- Cara: Q3 Earnings Snapshot - MySA
Astroworld plaintiff lawyers up with prominent San Antonio name ... The biotechnology company posted revenue of $20.3 million in the period, ...
- Krystal's new Pittsburgh gene therapy center to be operational in 2022 - The Business Journals
Pittsburgh-based Krystal Biotech Inc. affirmed Monday that its new $36 million gene therapy center, which is under construction in Findlay ...
- Spurs Updated Outlook: 2019 1st Rd Pick PF Luka Samanic Released | Editorials 24
The San Antonio Spurs updated Team Outlook after releasing 2019 1st Rd Pick PF Luka Samanic. Despite being a 1sr Rd Pick on a rebuilding team, ...